Alli (60 mg Orlistat Capsules) by GlaxoSmithKline Recalled due to Product Tampering
The FDA informs consumers that all Alli (60 mg Orlistat capsules), by GlaxoSmithKline, are recalled due to product tampering as some of the packages may contain product that is not authentic Alli.
Background of Alli (60 mg Orlistat Capsules)
Alli is marketed for weight loss in overweight adults used in combination with a reduced-calorie and low fat diet.
FDA Alert on Alli (60 mg Orlistat Capsules)
FDA’s reason for the recall is that the company received inquiries from consumers in seven states about tampered products: bottles of Alli that contained tablets and capsules that were not Alli and bottles inside the outer carton that were missing labels and had tamper-evident seals that were not authentic.
FDA Recommendation on Alli (60 mg Orlistat Capsules)
“Consumers who have product they are unsure or concerned about should not use it. Instead, they should call GSK promptly at 800-671-2554, and a representative will provide further instructions. If they have consumed questionable product, they should also contact their healthcare providers.”
AttorneyOne.com is a free nationwide legal referral service. We are not a law firm. We help consumers find the best representation for their legal needs.
If you or a loved one are in need of legal assistance concerning Law News you should get a lawyer on your side immediately. You will pay no attorney fees unless you win your case.
Email up to 10 Law News law firms in one click; by filling out the simple Free Case Evaluation form.
For additional info on Law News use the practice area links on the far right.